Director of Process Development Amgen05/2011 - 05/2016 Thousand Oaks, CA • Managed global process development projects, leading a team of 50+ scientists and engineers across multiple locations. • Successfully scaled up biopharmaceutical manufacturing processes, reducing production costs by 15%. ...
Circle Pharma announced today the appointments of Michael Cox, PharmD., MHSc, BCOP as senior vice president, head of Early Development, and Edward Garmey, M.D., as its new consulting chief medical officer.
Advised Horizon Therapeutics on its agreement to be acquired by Amgen for approximately $28 billion. Drafted and negotiated compensation issues for Insurance Auto Auctions (IAA) in its definitive merger agreement with Ritchie Bros. Advised Grindr on its definitive agreement to merge...
Michelle Yu Xia Akeso Biopharma, China Chairman, President & CEO Shou-Bai Chao AstraZeneca, China Senior Vice President Lars Dreesmann Boehringer Ingelheim Pharma, Germany Executive Director Richard O'Keeffe Amgen, Singapore Executive Director ...
(and hence between a longer career and a shorter one). Listening is a valuable skill that most executives spend little time cultivating. (For more about one executive’s desire to be a better listener, see “Why I’m a listener: Amgen CEO Kevin Sharer,” forthcoming on mckinseyquarterly....
Le Goff was actively engaged with the policy community and advocates for innovative, high-quality and affordable healthcare. She represented Amgen as a member of the Healthcare Leadership Council. Prior to joining Amgen, Dr. Le Goff held a number of senior international roles at R...
·Amgen -Director, R&D Strategic Operations and Finance, 2005-2007 -Associate Director/Director, Strategic Process Analysis, 2004-2005 ·McKinsey & Company -Engagement Manager/Senior Associate/Associate, 2000-2004 ·Lawrence Livermore National Laboratory ...